November 30, 2009
A recent study shows that even the most challenging diabetic wounds can be treated successfully with the L-Mesitran honey based products. In one of the most prestigious hospitals and reference centers of Asia, the Kuala Lumpur Hospital, a study was done to see whether L-Mesitran could prevent amputation and reduce antibiotic use.
In this study the L-Mesitran products have demonstrated convincingly:
- that wound infections were rapidly cleared;
- that additional antibiotics were not necessary;
- to prevent eminent (partial) DM foot amputation;
- to quickly debride wounds;
- to reduce wound size rapidly.
You can click here to download the poster.
Please do not hesitate to contact us, should you have questions about the presented study or if you're interested in participating in a similar study. |
